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Abstract
 .The composition and activity of cytochrome c oxidase COX was studied in mitochondria from rat liver, brain, kidney
and heart and also in different compartments of the bovine heart to see whether any correlation exists between known
oxidative capacity and COX activity. Immunoblot analysis showed that the levels of ubiquitously expressed subunits IV and
Vb are about 8–12-fold lower in liver mitochondria as compared to the heart, kidney and brain. The heart enzyme with
 .higher abundance of COX IV and Vb showed lower turnover number 495 while the liver enzyme with lower abundance of
these subunits exhibited higher turnover number of 750. In support of the immunoblot results, immunohistochemical
analysis of heart and kidney tissue sections showed an intense staining with the COX Vb antibody as compared to the liver
sections. COX Vb antibody stained certain tubular regions of the kidney more intensely than the other regions suggesting
region specific variation in the subunit level. Bovine heart compartments showed variation in subunit levels and also
differed in the kinetic parameters of COX. The right atrium contained relatively more Vb protein, while the left ventricle
 .contained higher level of subunit VIa. COX from both the ventricles showed high K for cytochrome c 23–37 mM asm
 .compared to the atrial COX K 8–15 mM . These results suggest a correlation between tissue specific oxidativem
capacityrwork load and changes in subunit composition and associated changes in the activity of COX complex. More
important, our results suggest variations based on the oxidative load of cell types within a tissue. q 1998 Elsevier Science
B.V.
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1. Introduction
 .Cytochrome c oxidase COX, EC 1.9.3.1 is the
terminal component of the respiratory chain that cat-
alyzes the reduction of dioxygen to water from the
electrons derived from ferrocytochrome c. COX is
one of the three centers that create a proton gradient
as an intermediate step in the conversion of redox
energy to ATP. In mammals the enzyme is composed
of 13 subunits and its biosynthesis involves a coordi-
nated interplay between the nuclear and mitochon-
 .drial genomes. The largest subunits I, II and III ,
which represent the catalytic core of the enzyme
complex are encoded by the mitochondrial DNA and
w xare synthesized within the mitochondrion 1,2 . The
rest of the smaller subunits IV, Va, Vb, VIa,b,c,
.VIIa, VIIb and VIII are encoded on the nuclear
DNA, synthesized in the cytosol, imported into mito-
chondria and assembled into the holoenzyme com-
w xplex 3 . Genetic studies in yeast have elucidated the
role of nuclear coded subunits in the assembly of the
enzyme complex, as well as in the modulation of
w xenzyme activity 4–6 . Nucleotide and reactive probe
binding studies with the mammalian enzyme sug-
gested a regulatory role for the nuclear coded sub-
w xunits 7,8 . Selective removal of the nuclear encoded
subunit VIb from the bovine heart enzyme complex
increased the activity of the enzyme suggesting an
w xinhibitory role for this subunit 9 . These and other
studies support the essential role of the nuclear en-
coded subunits in the catalytic activity of the enzyme
w x10,11 .
COX plays a major role in energy production and
it is believed to be a major regulatory site that
determines the mitochondrial respiration linked ox-
w xidative capacity 12 . Regulation of yeast COX by
w xoxygen has been well documented 13,14 . Oxygen
regulates the expression of subunit V isoforms in the
yeast. The isoform Va is expressed under aerobic
 .O )0.5 mM conditions and the isoform Vb is2
 .expressed under anaerobic O -0.5 mM condi-2
tions. The level of COX activity is determined by the
number of holoenzyme molecules assembled in the
presence or absence of Va or Vb. These isoforms
have been shown to affect the TN of holoenzyme by
altering the rates of intramolecular electron transfer
between heme a and the binuclear reaction center
w x13,14 . However, currently very little is known about
the effects of oxygen tension on the structure and
activity of the mammalian enzymes.
In previous studies from our laboratory, we ob-
served that though both COX IV and COX Vb are
constitutively expressed in all tissues, Vb mRNA was
found to be more abundant in the heart and kidney
w xand low in the liver and brain 15 . Additionally COX
Vb mRNA was found to be induced during the
w xdifferentiation of myoblasts into myotubes 15 . Since
heart is a tissue with higher mitochondrial abundance
and high energy demand as compared to the liver, it
would be interesting to see if the subunit composition
of COX in these tissues show any difference and if
there is any notable change in the COX activity.
Previous studies aimed at elucidating the role of
nuclear coded subunits in the activity of the mam-
malian COX enzyme arrived at some what different
conclusions mainly because of the different methods
wof enzyme isolation and assay conditions used 16–
x18 . We have, therefore, used mitochondrial mem-
brane fragments with a view to maintain the struc-
tural and functional integrity of the enzyme complex
and investigated tissue specific differences in enzyme
kinetics. Rat tissues which differ in energy demand
such as, heart, brain, kidney and liver and different
compartments of the bovine heart, which differ in the
workload and hemodynamic properties were chosen
as sources of the enzyme. Our results show marked
differences in the catalytic activity and subunit com-
position of COX in different tissues as well as car-
diac compartments.
2. Materials and methods
2.1. Preparation of mitochondria
Rat liver, heart, kidney and brain mitochondria
w xwere isolated as described earlier 19 following ho-
mogenization in H medium 70 mM sucrose, 220
mM mannitol, 2.5 mM HEPES, pH 7.4 and 2 mM
.EDTA and differential centrifugation. The heart was
first minced in a polytron before homogenizing in a
motor driven Potter–Elvejham homogenizer. Brain
mitochondria were isolated following a two step Per-
w xcoll gradient 20 . Beef hearts were obtained from a
slaughter house immediately after the animal was
sacrificed and separated into right and left atria and
right and left ventricles and the septal wall. The
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mitochondria were prepared using a high speed
blender in a medium containing 0.25 M sucrose, 0.01
 .M Tris–HCl pH 7.8 , 1 mM succinate and 0.2 mM
w xEDTA 21 . Submitochondrial particles were pre-
w xpared according to the method of Pedersen et al. 22 .
All operations were performed at 48C.
2.2. Spectrophotometric measurements of COX acti˝-
ity in the steady state
w xCOX was assayed by the method of Smith 23
wherein the rate of oxidation of ferrocytochrome c
was measured by following the decrease in ab-
sorbency of its a band at 550 nm. Steady state
activity assay conditions were similar to that de-
w xscribed by Sinjorgo et al. 17 . The 1-ml reaction
 .medium contained either 10 mM low ionic strength
 . y2  .or 100 mM high ionic strength PO pH 7.0 ,4
0.05% lauryl maltoside, 1 mM EDTA and 1–2 mg of
protein in the form of submitochondrial particles.
Ferrocytochrome c was added to a concentration of
0.12–80 mM. Reaction rates were measured using
Cary-1E spectrophotometer. First order rate constants
were calculated from mean values of four to six
measurements at each ferrocytochrome c concentra-
tion. The cytochrome aa content of enzyme prepara-3
tions were calculated from the difference spectra
dithionaterascorbate reduced minus ferricyanide ox-
.idized of mitochondria or submitochondrial particles
solubilized in 2% deoxycholate using an absorption
 . y1 y1 w xcoefficient at 605–630 nm of 16 mM cm 24 .
All spectral measurements and enzyme assays were
performed at ambient temperature in phosphate buffer.
Protein concentrations were estimated by the method
w xof Lowry et al. 25 .
2.3. Electrophoresis of proteins and Western blot
analysis
Proteins were subjected to electrophoresis on 12–
18% SDS–acrylamide gels as described by Laemmli
w x26 . The conditions for Western blot analysis and
immunodetection of proteins were as described ear-
w xlier 27 . Specific antibody interactions were tested by
probing with polyclonal or monoclonal antibodies
and bound secondary antibody was detected and
quantitated by incubating the membrane with chemi-
fluorescent vista ECF substrate according to manu-
facturer’s protocol Amersham Life Sciences, Arling-
.ton Heights, IL . Polyclonal antibody against purified
mouse COX was developed in rabbit using standard
methods. Subunit specific monoclonal antibodies for
COX I, Vb, VIa, and VIc were obtained from Molec-
ular Probes, Eugene, OR, and the specificity of each
antibody was verified by Western blot analysis of
proteins from the rat liver and heart SMP as well as
purified COX. Blots were quantified with an Image
Scanner STORM Molecular Dynamics, Sunnyvale,
.CA .
2.4. Northern blot analysis
Total RNA was extracted from rat tissues and
bovine cardiac compartments by solubilization in
guanidine thiocyanate followed by phenol extraction
w x28 . Denatured RNA samples were resolved by elec-
trophoresis on formaldehyde containing agarose gels
and transblotted to Nytran nylon membrane and hy-
bridized using standard conditions described in the
Schleicher and Schuell laboratory manual. COX sub-
unit specific synthetic oligonucleotides 28–36 bases
. Xlong were 5 end labelled using T4 Polynucleotide
 . wKinase New England Biolabs, Beverly, MA and g
32 x  .P ATP Amersham , and used as probes. The RNA
loading was monitored by probing the blots with 32P
w xlabelled 18S rDNA probe 29 . The northern blots
were quantitated by scanning through a Phosphorim-
 .ager ‘Storm’ system Molecular Dynamics .
2.5. Oligonucleotides
The sequences for oligonucleotide probes were as
follows.
COX I: 5X-AATGTGTGATATGGTGGAGGG-
CATCC-3X;
C O X IV : 5 X-C C T G T T C A T C T C G -
GCGAAGCTCTC-3X;
COX Vb: 5X-ACCAGCTTGTAATGGGTTCCA-
CAG-3X;
 . XCOX VIII H : 5 -AGTGGGTGTTCTGGCTG-
GCTTGGCAGTGAT-3X.
2.6. Immunohistochemistry
Adult female mice were anesthetized with a mix-
ture of ketamine and xylazine 10:7.5, 1.5 mlrkg,
.i.p. . All animals were perfused through the left
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cardiac ventricle with 20 ml heparinized saline 1
.urml of heparin in 0.15 M NaCl followed by 60 ml
cold Zambonis fixative 4% paraformaldehyde and
.15% saturated picric acid in 0.1 M phosphate buffer .
The heart, kidney, liver and brain were postfixed
overnight in the same fixative containing 20% su-
crose. All four organs were embedded on a single
tissue stage with embedding medium Tissue-TEK,
.Miles , cut into 8-mm thick sections in a cryostat at
y188C, and mounted on a single glass slide. The
 .tissues were incubated in a drop 200 ml of mono-
 .  .clonal antibody to COX I 1:50 , COX Vb 1:200 ,
 .  .COX VIa 1:100 or COX VIc 1:100 at 258C for 20
h. The primary antibodies were diluted in 0.01 M
 .phosphate buffered saline PBS containing 0.3% Tri-
ton X-100 and 2% normal donkey serum. Sections
incubated in a drop of same buffer without any
primary antibody served as controls. All sections
were then incubated in 1:100 rhodamine–isothio-
cyanate conjugated donkey anti-mouse secondary an-
 .tibody Jackson Lab, NJ at 258C for 3 h. After each
step, sections were rinsed with 0.01 M PBS 3=10
.min . Finally, the sections were observed under a
Leitz fluorescent microscope and photographed.
3. Results
3.1. Immunoblot analysis of COX subunits in differ-
ent tissues
To minimize the loss of subunits that is inherent in
various purification protocols, involving fractionation
with different detergents, andror high salt extraction,
we have used submitochondrial particles for the
Western immunoblot analysis. Since tissues differ in
mitochondrial abundance and hence, in heme aa3
content, proteins from different tissues were loaded
on the gel based on equal heme content, rather than
total protein content. Blots containing mitochondrial
proteins from rat tissues that have been probed with
polyclonal antibody to subunit IV, and monoclonal
antibodies to subunits Vb and VIc are shown in Fig.
1A and B. On equal heme basis, the rat liver enzyme
contained 8–10-fold lower levels of immunodetect-
able COX IV and Vb protein as compared to COX
from heart, brain and kidney. The levels of these
subunits in complexes from heart, brain and kidney
Fig. 1. The immunoblot analysis of mitochondrial proteins from
 .different rat tissues. A The blots containing equal amount of
 .COX 100 nmol of heme aa from each tissue was probed with3
 .monoclonal anti-bovine antibodies COX Vb and VIc or poly-
 .clonal anti-rabbit antibody COXIV followed by the appropriate
alkaline phosphatase conjugated secondary antibodies. The blots
were then incubated with chemifluorescent substrate vistaECF,
.Amersham and the signals were detected and quantified with an
 .  .Image scanner STORM Molecular Dynamics . B Histogram
showing the relative abundance of COX subunits by scanning the
 .immunoblot in A . The results represent an average of two
separate experiments which showed less than 10% margin of
error.
showed only marginal variations, and may account
 .for a near normal 1:1 stoichiometry. A markedly
lower levels of subunit IV and Vb in the liver may
reflect substoichiometric levels of these subunits in
the liver COX complex. The results also show no
significant variation in the levels of the antibody
cross-reactive subunit VIc in complexes from all the
four tissues tested. Although not shown, the levels of
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mitochondrial genome encoded subunits I and II did
not vary significantly in all the four tissue samples
loaded on the basis of equal heme content.
3.2. Steady state kinetics of COX from different tis-
sues
The role of nuclear coded subunits in COX activity
was probed by studying the reaction kinetics of the
enzyme from different tissues. In most of the earlier
studies, COX was assayed following partial or com-
plete purification of the enzyme from a given source.
These studies found that the buffer composition, pH,
ionic strength, detergent and lipid composition influ-
w xenced the COX activity 18 . To circumvent these
problems we have used submitochondrial particles
prepared by sonication for enzyme activity measure-
ments. The membrane particles were solubilized in
the presence of saturating amounts of laurylmalto-
side, a non-ionic detergent that has been shown to
w xprevent aggregation of COX 17 .
The steady state kinetics of COX measured spec-
trophotometrically in submitochondrial particles from
different tissues are presented in Table 1. In keeping
Table 1
The kinetic parameters of rat cytochrome c oxidase isoenzymes
Isoenzyme Steady state
Is27 mM Is226 mM
High affinity Low affinity K TNm
y1 .  .mM sK TN K TNm m
y1 y1 .  .  .  .mM s mM s
Brain 4 55 23 160 8 500
Heart 2 35 13 100 26 495
Kidney 3 80 37 200 9 340
Liver 3 120 22 200 8 750
The steady state reaction rates were determined by photometric
2y  .assay in 1 ml medium containing either 10 mM PO low ionic4
2y  .or 100 mM PO high ionic , 0.05% laurylmaltoside, 1 mM4
EDTA, 1–2 mg mitochondrial membranes and 0.16–80 mM
ferrocytochrome c. First order rate constants were calculated
from mean values of four to six readings at each ferrocytochrome
c concentration. At high ionic strength, the K and TN valuesm
were determined directly from the straight line Eadie–Hofstee
plots. The low ionic concave Eadie–Hofstee plot was resolved
into two first degree functions and K and TN values of low andm
high affinity reactions were calculated from computer analysis as
w xdescribed earlier by Sinjorgo et al. 30 .
Fig. 2. The Eadie–Hofstee plots of steady state kinetics of COX
at low ionic media. Spectrophotometric measurements were car-
2y  .ried out in 10 mM PO pH 7.0 , 0.05% laurylmaltoside, 1 mM4
 .EDTA and 0.12–80 mM ferrocytochrome c. SMP 1–2 mg
from different rat tissues was used as the source of enzyme. An
average of four to six measurements at each concentration of
cytochrome c was used to calculate the first order rate constants.
w xwith previous studies 17 , spectrophotometric mea-
surements of reaction kinetics in a medium of high
 y2 .ionic strength conditions 100 mM PO yielded a4
 .straight line Eadie–Hofstee plot results not shown .
In contrast, reaction kinetics in a low ionic strength
 y2 .medium 10 mM PO resulted in concave Eadie–4
Hofstee plots which represented the sum of two
w xMichaelis–Menten rate equations 17,30 . Fig. 2
shows that steady state reactions of the COX from rat
liver, heart, brain and kidney SMP when measured in
 .a medium containing low ionic strength Is27 mM
buffer. Similar biphasic curves for COX activity at
low ionic strength were reported previously with
w xbovine heart SMP 30 . A comparison of values for
submitochondrial particles from various tissues show
differences in K and TN values both at low andm
 .high ionic strength conditions Table 1 . At high
 y2 .ionic strength 100 mM PO , which mimics the4
physiological conditions, the heart enzyme exhibited
 .  .higher K 26 mM and lower TN 495 whenm
 .compared to the liver enzyme with a low K 8 mMm
 .and high TN 750 . Under the same physiological
conditions, both the brain and kidney enzymes showed
K values similar to liver. However, their TN valuesm
were 40–50% lower than that of the liver enzyme.
Both at low and high ionic conditions, the liver
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enzyme had generally higher TN values than enzyme
from other tissues. In contrast, the high and low
affinity phase K values 2 and 13 mM, respec-m
.tively for the heart enzyme at low ionic condition
were significantly lower than those of other tissues
 .see Table 1 . The difference in K and TN valuesm
between the tissues ranged 2–3-fold and probably
reflects the tissue specific variation in the microenvi-
ronment of the enzyme.
3.3. Immunohistochemistry
The possibility of subunit Vb variation as observed
in Fig. 1 was further investigated by immunohisto-
chemical analysis of paraformaldehyde and picric
acid fixed tissue sections. As shown in Fig. 3A,
antibody to Vb gave a uniform, and relatively light
staining of the liver sections. In support of the west-
ern blot data in Fig. 1, the heart sections were stained
 .more intensely as compared to the liver see Fig. 3B ,
suggesting differences in the abundance of the sub-
unit in these tissues. It is also seen that the staining
pattern of the heart sections were non-uniform, with
some regions staining more intensely than the other
suggesting intra-tissue heterogeneity in the level of
COX Vb. Sections from mouse kidney cortex region
 .Fig. 3C showed even more dramatic heterogeneous
staining with COX Vb antibody. Some of the tubules
with characteristic thick walls, were stained more
intensely as compared to tubular structures with thin
 .  .  .Fig. 3. The immunohistochemical localization of COX Vb in mouse liver, heart and kidney. A liver scale bars100 mm , B heart
 .  .  .  .  .scale bars100 mm , C kidney scale bars100 mm and D liver, preimmune IgG control scale bars50 mm . Sequential sections
were incubated with anti-COX Vb monoclonal antibody and visualized by rhodamine isothiocyanate conjugated anti mouse IgG donkey
 .antibody. Section in D was developed using pre-immune IgG.
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walls. This intra-tissue heterogeneity in COX Vb
level is consistent with the known heterogeneity in
the level of oxidative metabolism in different com-
partments of kidney. Fig. 3D represents a control in
which, a representative liver section was stained
without added COX Vb antibody.
To investigate if the differential staining of the
kidney regions represented the mitochondrial abun-
dance in these cells, companion sections were probed
with antibodies to mitochondrial encoded subunit I
and a ubiquitous nuclear encoded subunit VIc. In
contrast to a non-uniform discriminating pattern ob-
 .tained with the Vb antibody Fig. 4A , both subunit
 .  .VIc Fig. 4B and subunit I Fig. 4D yielded more
uniform staining patterns. Fig. 4C represents a higher
magnification of the COX Vb antibody stained pat-
tern shown in Fig. 4A. In Fig. 4E, a representative
kidney section was stained without added primary
antibody. These results suggest a possible intra-tissue
heterogeneity in the abundance of COX Vb, possibly
based on the oxidative, andror metabolic load of the
cell type.
3.4. COX subunit stoichiometry and acti˝ity in bo˝ine
cardiac compartments
To determine whether the level of mitochondrial
and nuclear encoded mRNAs follow compartmental
specific variations, equal amounts of total RNA from
cardiac compartments were hybridized with subunit
 .  .  .Fig. 4. The immunohistochemical localization of COX I, Vb and VIc in mouse kidney. A anti-COX Vb scale bars250 mm , B
 .  .  .  .  .  .anti-COX VIc scale bars100 mm , C anti-COX Vb scale bars100 mm , D anti-COX I scale bars50 mm and E preimmune
 .IgG scale bars100 mm . Sequential sections were incubated with anti-COX Vb monoclonal antibody and visualized by rhodamine
isothiocyanate conjugated anti-mouse IgG donkey antibody.
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Fig. 5. The relative abundance of the COX mRNAs in different
 .compartments of the bovine heart. A Northern blot analysis:
 .total RNA 30 mg from each cardiac compartment was separated
on agarose–formaldehyde gel, transferred to nitrocellulose and
hybridized with 32P labelled subunit specific oligonucleotide
probes. The blots were stripped and rehybridized with 18S rDNA
 .probe to determine the loading level in each lane. B The
autoradiograms in A were quantitated using an AGFA Arcus II
scanner and the NIH image quantitation system. The values were
normalized to the 18S rRNA level in each lane.
specific synthetic oligonucleotide from the conserved
region of mRNAs. The relative abundance of mRNAs
for different subunits in the bovine cardiac compart-
ments is presented in Fig. 5A and B. Both the right
and left atrial compartments showed higher levels of
COX I, IV and Vb mRNAs. The right and left
ventricles contained marginally varying levels of all
the mRNAs studied. The left and right atrial compart-
ments contained nearly 2–3-fold higher abundance of
COX IV mRNA than the septal and ventricular com-
partments.
Fig. 6 shows immunoblot analysis using submito-
chondrial particles from different bovine cardiac
compartments. The COX from right atrium contained
1.6–2.2-fold higher levels of COX Vb protein as
Fig. 6. The immunoblot analysis of mitochondrial proteins iso-
 .lated from bovine cardiac compartments: In A the blots contain-
 .ing equal amount of COX 100 nmol of heme aa from each3
cardiac compartment was probed with monoclonal anti-bovine
 .antibodies COX Vb, VIa and VIc or polyclonal anti-rabbit
 .antibody COX IV . The immunoblot analysis was carried out as
 .described in Fig. 1. B Histogram shows the relative abundance
of COX subunits in mitochondria from different cardiac compart-
ments.
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Table 2
The kinetic parameters of bovine cardiac compartmental cy-
tochrome c oxidase
Isoenzyme Steady state
Is27 mM Is226 mM
High affinity Low affinity K TNm
y1 .  .mM sK TN K TNm m
y1 y1 .  .  .  .mM s mM s
Left ventricle 5 15 32 75 32 110
Right ventricle 4 20 48 80 28 105
Left atrium 2 20 11 85 8 105
Right atrium 1 10 26 60 19 95
Septum 2 15 27 75 22 110
The steady state reaction rates were determined by photometric
2y  .assay in 1 ml medium containing either 10 mM PO low ionic4
2y  .or 100 mM PO high ionic , 0.05% laurylmaltoside, 1 mM4
EDTA, 1–2 mg mitochondrial membranes and 0.16–80 mM
ferrocytochrome c. The K and TN values were calculated asm
described in Table 1.
compared to the COX from other three compart-
ments, i.e., the left atrium and both right and left
ventricles. While subunit VIa content of COX was
nearly similar in septum and atrial compartments, its
level varied more than 2-fold between the left and
right ventricles. The levels of COX IV and VIc
subunits varied only marginally between the compart-
ments.
Kinetic parameters for cardiac compartmental COX
is presented in Table 2. There were minor differences
in TN and K values between the right and leftm
ventricular as well as septal compartments at both
low and high ionic strength conditions. Right atrial
enzyme exhibited lowest TN. The left atrial compart-
ment showed lower K values and a TN valuem
similar to that of left and right ventricles and septum.
The K values between left and right atrium differedm
significantly with respect to high and low affinity
phase binding sites for cytochrome c. The ventricular
compartments differed significantly in their kinetic
properties from the atrial compartments. COX from
both the ventricles showed high K for cytochromem
 .c 28–32 mM as compared to the atrial COX which
showed a lower K of 8–19 mM. These resultsm
provide insight on the inter-compartmental variations
in the subunit composition and catalytic activity of
COX in the cardiac tissue.
4. Discussion
Despite continued efforts in various laboratories,
the functional roles of nuclear encoded ubiquitous
and tissue specific isologs of COX in mammalian
w xorganisms remain unclear 1,31 . Subunit VIa has
been extensively studied in this regard, and has been
suggested to modulate enzyme activity possibly
w xthrough nucleotide binding 8 . Studies in yeast have
indicated that the nuclear coded smaller subunits
influence the enzyme activity. The modulatory role of
yeast COX subunit V isoforms, Va and Vb, in en-
zyme turnover as yeast switches from aerobic to
w xanaerobic and vice versa is well documented 13 .
Unlike the yeast, mammals depend entirely on oxy-
gen for their survival. Under normal conditions when
O is not a limiting factor, the function of COX is2
solely determined by metabolic demands of the tis-
sues. Based on the findings that some of the nuclear
coded non-catalytic COX subunits are expressed as
 .  . w xthe liver L and muscle specific H isologs 32,33 ,
it has been postulated that these subunits might have
a modulatory role in enzyme function. In extension of
these possibilities, our results suggest that ubiqui-
tously expressed subunits IV and Vb may also have
roles in the modulation of COX activity under certain
physiological condition.
Though the nuclear coded IV and Vb subunits are
constitutively expressed in all the tissues the results
presented in this study show that the COX from
 .tissues with higher energy demand O consumption2
contain higher levels of IV and Vb proteins. Liver
with a lower energy demand and thus lower O2
consumption contained lower levels of COX IV and
Vb protein subunits. These observations are consis-
tent with the previous studies showing 5–15-fold
higher levels of COX Vb and IV mRNAs in the heart
w xas compared to the liver 15,34 . A comparison of
results in Figs. 5 and 6 show some degree of disparity
in the steady state mRNA levels and subunit contents
in different compartments of the heart. For example,
both left and right atria contain nearly 2-fold higher
levels of COX IV mRNAs as compared to other
compartments although COX from all four compart-
ments contain nearly similar subunit contents. This
difference may largely be due to post-transcriptional
or translational regulation, reported for different COX
subunits under different physiological and develop-
( )C. Vijayasarathy et al.rBiochimica et Biophysica Acta 1371 1998 71–8280
w xmental conditions 35–39 . Results in Fig. 6 also
show that COX from right atrium and left ventricle
contain nearly 2-fold higher levels of subunits Vb
 .and VIa nearly 2-fold stoichiometry , respectively,
as compared to near normal stoichiometric levels in
COX from other compartments. Although reasons for
the higher Vb and VIa contents of the right atrial and
left ventricular complexes, respectively, remains un-
known, it may be related to the biogenesis or activi-
ties of the respective COX complexes or reflects a
yet unknown multifunctional properties of these two
subunits.
Initial studies with bovine cytochrome c oxidase
 .when assayed at low ionic condition -25 mM
showed that the steady state reaction rates do not
w xfollow a simple Michaelis–Menten rate kinetics 40 .
Since then, a number of studies have shown that at
low ionic strength the reaction yields a concave
Eadie–Hofstee plot which represents two first degree
functions, suggesting two separate rate kinetics corre-
 .sponding to a high affinity low K and low affinitym
 . w xhigh K reactions 30,41 . The high affinity reac-m
tion is believed to be due to cytochrome c binding to
subunit II of COX, which is also described as the
w xcatalytic site 42 . The low affinity or non-catalytic
site was shown to be due to cytochrome c binding to
w xcardiolipin through electrostatic interaction 42,43 .
The straight line Eadie–Hofstee plots obtained under
high ionic conditions is thought to be analogous to
w xhigh affinity reaction at low ionic strength 44 . It is
suggested that high ionic conditions essentially re-
duce the low affinity binding of ferrocytochrome c
by interfering with electrostatic interaction. Although
reactions under high ionic condition is believed to be
physiologically important, the differences in kinetic
rates under low ionic conditions are important param-
eters for comparing COX from different tissues under
different microenvironments, including different sub-
unit compositions. We have therefore, carried out
activity measurements under both of these conditions
to gain insight on tissue specific differences in COX
complex.
Kinetic characterization of the isoenzymes reveal
sharp differences in enzyme activity between the
tissues. We postulate that these kinetic parameters
reflect observed differences in subunit stoichiometry
of the COX enzyme. While the heart isoenzyme with
a higher abundance of COX IV and Vb protein
showed lower TN, the liver enzyme with a lower
abundance of COX IV and Vb exhibited higher TN.
Our results, therefore, suggest an inverse relationship
between COX IV and Vb abundance and correspond-
ing changes in the kinetic properties of the enzyme.
In initial studies using spectrophotometric assays
under high ionic strength conditions, Kadenbach et
w x w xal. 16 and Sinjorgo et al. 17 reported similar
reaction kinetics for bovine COX purified from heart,
skeletal muscle, liver and kidney with their known
differences in the tissue specific isolog contents.
These results therefore suggested that the nuclear
encoded subunits might not influence the catalytic
activity of the enzyme COX. In a series of subse-
w xquent studies, Kadenbach et al. 16 demonstrated
that the bovine liver and heart COX reconstituted in
phospholipid vesicles exhibited different reaction ki-
netics. These and subsequent studies suggested that
the organ linked variation in nuclear coded subunits
is an adaptation to differences in phospholipid com-
w xposition of the mitochondrial membranes 44,45 . It
was also shown that reconstituted bovine heart COX,
but not the liver COX, responds to intra-liposomal
ADP. This response was stimulated by monoclonal
antibody to COX VIa, probably by inducing a confor-
w xmational change in the enzyme complex 8 . These
studies strongly support the possibility that the modu-
lation of COX activity by lipids is mediated by
nuclear coded subunit VIa. The stimulatory role of
cardiolipin and free fatty acids on COX activity have
w xalso been documented 18,46 . Stimulation of COX
activity in hyperthyroid rat was solely attributed to
w xthe increase in membrane cardiolipin content 47 .
In support of the above listed studies, under near
native conditions the liver isoenzyme exhibits low
K and high TN, in tune with its low O consump-m 2
tion rate. On the other hand, heart, with high oxida-
tive capacity, shows low TN and a higher K , possi-m
bly a mechanism to prevent oxidative injury. The
isoenzymes of brain and kidney whose O consump-2
tion rates are lower than that of the heart, but higher
than that of liver exhibit intermediate kinetic proper-
ties. The kidney isoenzyme presented a unique pic-
ture. While its TN at high ionic condition reflected it
 .to be a heart like isoenzyme high oxidative capacity ,
at low ionic state it resembled the COX from a tissue
with low oxidative capacity, such as liver, possibly
because of mixed population. This interpretation is
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consistent with the known variations in the levels of
oxidative metabolism between the cortical and
medullary regions of the kidney.
Within the heart tissue, different compartments
with varying workloads exhibited heterogeneity in
subunit stoichiometry. While Vb was more abundant
in right atrium, left ventricle contained a higher level
of VIa. Though a direct link between subunit abun-
dance and kinetic properties of the cardiac compart-
mental isoenzymes is not apparent, the ventricular
compartments differed significantly from atrial com-
partments in their kinetic properties. Though the left
ventricular output is known to be slightly greater than
that of right ventricle, both the ventricular compart-
ments exhibited similar kinetic properties for the
COX enzyme. Atrial compartments with a lower
 .workload low O consumption differed signifi-2
cantly from ventricular compartments. Under high
ionic conditions, all the heart compartments showed
essentially similar TN. The higher abundance of Vb
in right atrium is consistent with its lower TN. It is
quite likely that the heart specific COX VIa or COX
VIII may also be involved in fine tuning of the
cardiac compartmental COX enzymes. This is consis-
tent with our observation that COX VIa is differen-
tially distributed within the cardiac compartments,
with a higher abundance in the left ventricle.
5. Conclusion
Our results using enzyme complex with structural
and functional integrity close to the native mitochon-
drial membrane associated COX define a link be-
tween oxygen dependency of the tissue, the abun-
dance of nuclear coded COX IV and Vb subunits and
the kinetic properties of the isoenzymes. Through the
immunoblot and immunohistochemical analyses, we
demonstrate for the first time, an inter and intra tissue
specific differences in the COX subunit levels. Al-
though the precise mechanisms of altered kinetic
parameters remain unknown, our results open up the
possibility of using tissue regions or cells containing
high and low Vb subunit contents to address these
questions. The higher expression of COX VbrIV
might be an adaptive mechanism employed by the
highly oxidative tissues like heart, brain and proximal
convoluted tubules of the kidney to prevent oxygen
mediated injury.
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